Cryo-Cell International, Inc.

Cryo-Cell International, Inc. is the world's first private cord blood bank, established in 1989. The company specializes in cryopreservation and long-term storage of umbilical cord blood and cord tissue stem cells for families and biopharmaceutical clients. With over 500,000 clients across 87 countries, Cryo-Cell processes and preserves newborn stem cells using proprietary PrepaCyte-CB technology to maximize cell recovery and viability. The company operates FDA-registered, FACT-accredited facilities near Tampa, Florida, and maintains rigorous quality standards throughout collection, processing, and storage. Beyond private banking for families, Cryo-Cell provides public banking services in partnership with Duke University and offers ExtraVault biostorage services to biopharmaceutical companies. The company's preserved stem cell inventory supports ongoing clinical research into regenerative medicine applications for conditions including cerebral palsy, leukemia, and other disorders. Cryo-Cell holds quality accreditations from FACT and AABB, operates globally through licensing agreements in 15+ countries, and continues to advance stem cell banking and regenerative medicine research.